|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600126940 |
|
最近更新日期: Date of Last Refreshed on: |
2026-06-19 08:44:52 |
|
注册时间: Date of Registration: |
2026-06-19 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
年轻女性乳腺癌患者类更年期综合征护理干预方案构建及应用 |
|
Public title: |
Construction and application of nursing program for treatment-induced menopause in young women with breast cancer |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
年轻女性乳腺癌患者类更年期综合征护理干预方案构建及应用 |
|
Scientific title: |
Construction and application of nursing program for treatment-induced menopause in young women with breast cancer |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
丁彤 |
研究负责人: |
徐东升 |
|
Applicant: |
Ding Tong |
Study leader: |
Xu Dongsheng |
|
申请注册联系人电话: Applicant telephone: |
+86 186 8632 3435 |
研究负责人电话: Study leader's telephone: |
+86 138 4401 2022 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
dingtong24@mails.jlu.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
1479334114@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
吉林省长春市朝阳区吉林大学新民校区 |
研究负责人通讯地址: |
吉林省长春市朝阳区新民大街吉林大学白求恩第一医院 |
|
Applicant address: |
Student Seventh Apartment, Xinmin Campus, Jilin University, Chaoyang District, Changchun City, Jilin Province |
Study leader's address: |
71 Xinmin Street, Chaoyang District, Changchun, Jilin |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
吉林大学 |
||
|
Applicant's institution: |
Jilin University |
||
|
研究负责人所在单位: |
吉林大学第一医院 |
||
|
Affiliation of the Leader: |
Jilin University First Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
26K051-001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
吉林大学第一医院伦理委员会 |
||
|
Name of the ethic committee: |
The Ethics Committee of the First Hospital of Jilin University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-01-30 00:00:00 |
||
|
伦理委员会联系人: |
姜晶 |
||
|
Contact Name of the ethic committee: |
Jiang Jing |
||
|
伦理委员会联系地址: |
吉林省长春市朝阳区新民大街71号 |
||
|
Contact Address of the ethic committee: |
71 Xinmin Street, Chaoyang District, Changchun, Jilin |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 431 8878 2013 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
吉林大学第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Jilin University First Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
吉林大学吉林省长春市朝阳区新民大街71号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
71 Xinmin Street, Chaoyang District, Changchun, Jilin |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
self-raised |
||||||||||||||||||||||
|
Target disease: |
Breast cancer |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
基于Fitch理论对年轻女性乳腺癌患者类更年期综合征构建的护理方案,通过用户画像技术分层护理干预精准化改善患者类更年期综合征症状。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on the Fitch theory, a nursing plan for menopausal-like syndrome in young female breast cancer patients was constructed. Through user profiling technology, stratified nursing intervention was carried out to precisely improve the symptoms of menopausal-like syndrome in patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.经病理学确诊为乳腺癌的女性; 2.年龄18-40岁; 3.既往或正在接受以化疗为基础的联合治疗方案; 4.改良 Kupperman 评分量表总积分≥15 分者; 5.自愿参加并签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Women diagnosed with breast cancer by pathology; 2. Age between 18 and 40 years; 3. Have received or are currently receiving a combined treatment plan based on chemotherapy; 4. Total score on the Modified Kupperman Rating Scale >= 15 points; 5. Voluntarily participate and sign the informed consent form. |
||||||||||||||||||||||
|
排除标准: |
1.曾接受子宫及双侧卵巢切除术者; 2.合并其他导致性激素水平异常的疾病(如肝硬化、卵巢肿瘤等); 3.合并严重心、脑、肝、肾、造血系统等原发性疾病; 4.存在严重认知障碍或精神疾病史。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Those who have undergone hysterectomy and bilateral oophorectomy; 2. Those with other diseases that cause abnormal sex hormone levels (such as liver cirrhosis, ovarian tumors, etc.); 3. Those with severe primary diseases in the heart, brain, liver, kidney, hematopoietic system, etc.; 4. Those with severe cognitive impairment or a history of mental illness. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-06-08 00:00:00至 To 2027-03-08 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2026-06-20 00:00:00 至 To 2026-08-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
将纳入的86人按照不同画像分进A、B、C三个层中,假设符合A层(高症状-高需求)符合患者为86人,通过Excel随机数字在表格中将86名患者姓名进行编号依次列出,第二列中“输入RAND()”将86人产生随机数字,通过升序排列,将前43位患者纳入干预组,后43为患者纳入对照组,B、C层方法同上。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The 86 individuals included were divided into three layers (A, B, and C) based on different profiles. Assuming that 86 individuals met the criteria for layer A (high symptoms - high demands), the names of these 86 patients were numbered randomly in an Excel table and listed in sequence. In the second column, "INPUT RAND()" generated random numbers for the 86 individuals. By sorting in ascending order, the first 43 patients were included in the intervention group, and the last 43 patients were included in the control group. The methods for layers B and C were the same as above. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
对结局评估者设盲 |
|
Blinding: |
Blinding the outcome assessors |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
通过电子问卷进行收集,数据采用双人录入 Excel 数据库,确保准确性;原始问卷和数据记录保存于研究机构的专用文件柜,电子数据备份至加密硬盘,保存时间至少 5 年。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The data was collected through electronic questionnaires and was entered into the Excel database by two people to ensure accuracy. The original questionnaires and data records were stored in the dedicated filing cabinets of the research institution, and the electronic data was backed up to an encrypted hard drive and preserved for at least 5 years. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |